The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
By 2030, How Much Growth In Market Size Is Expected For The Gene Transplant Market?
The gene transplant market has expanded considerably over recent years. It is projected to rise from $4.13 billion in 2025 to $4.67 billion in 2026, displaying a compound annual growth rate (CAGR) of 13.1%. The historical expansion can be attributed to several factors including advancements in cell and gene therapy research, an uptick in clinical trial activity, the expansion of programs for treating rare diseases, increasing investment in regenerative medicine, and improvements in gene delivery technologies.
The gene transplant market size is projected to experience significant expansion in the coming years, reaching $7.57 billion by 2030, driven by a compound annual growth rate (CAGR) of 12.8%. This anticipated growth over the forecast period is fueled by several factors, including a rise in regulatory approvals for gene therapies, an increased need for personalized oncology treatments, the broadening of allogeneic therapy pipelines, enhanced investment in gene therapy manufacturing, and greater collaboration between biotechnology companies and healthcare institutions. Key trends identified for this period encompass a greater adoption of autologous gene therapies, the increasing application of CAR-T cell treatments, the continuous development of off-the-shelf gene therapies, an expansion in clinical gene transplant trials, and a heightened emphasis on personalized genetic treatments.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28232&type=smp
Which Growth Factors Are Strengthening The Gene Transplant Market Landscape?
The increasing prevalence of gene therapy is projected to fuel the expansion of the gene transplant market moving forward. Gene therapy, a medical method, involves modifying or manipulating an individual’s genes to address or prevent diseases. This growth in gene therapy is attributed to advancements in delivery systems, which allow for the safe, efficient, and targeted transportation of genetic material into cells. Gene therapy assists in managing genetic disorders by offering specific treatments that correct or replace faulty genes, making it a promising avenue for conditions that were previously incurable. It also mitigates disease symptoms and progression by tackling the fundamental genetic cause, thereby enhancing patient outcomes and their quality of life. For instance, in December 2024, data from the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, showed that the Food and Drug Administration (FDA) authorized six gene therapy products in 2023, an increase from five approvals in 2022. Thus, the growing adoption of gene therapy is propelling the gene transplant market’s growth.
How Is The Gene Transplant Market Structured Across Different Market Segments?
The gene transplant market covered in this report is segmented –
1) By Type: Autologous, Allogeneic
2) By Application: Genetic Disorders, Cancer, Rare Diseases, Other Application
3) By End-User: Hospitals, Research Institutes, Biotechnology Companies, Other End-Users
Subsegments:
1) By Autologous: Hematopoietic Stem Cell Transplantation, Gene-Modified Autologous Cell Therapy, Chimeric Antigen Receptor T (CAR-T) Cell Therapy
2) By Allogeneic: Hematopoietic Stem Cell Transplantation, Gene-Modified Allogeneic Cell Therapy, Allogeneic Chimeric Antigen Receptor T (CAR-T) Cell Therapy, Off-The-Shelf Gene Therapies
What Trends Are Affecting The Growth Of The Gene Transplant Market?
Leading companies within the gene transplant market are concentrating their efforts on advancing solutions, such as automated cloning platforms, to enhance efficiency, improve precision, and expedite the creation of gene therapies. These automated cloning platforms are systems capable of autonomously isolating and cultivating single cells into monoclonal lines, which significantly boosts speed, accuracy, and consistency for gene transplant and therapeutic uses. As an illustration, in November 2024, iotaSciences Ltd., a UK-based life sciences technology company, unveiled its XT Single-Cell Cloning Platform, an automated cloning platform. This integrates automated microfluidics, AI-driven image analysis, and nano-dispensing technology to enable high-throughput, precise isolation and cloning of individual cells. The platform is designed to accelerate gene therapy development by ensuring monoclonality, a critical regulatory prerequisite, while concurrently decreasing processing duration from weeks to days. Moreover, this system also supports CRISPR-based gene editing applications by facilitating the efficient delivery of editing components to target cells, thereby fostering the progression of next-generation therapies.
Who Are The Businesses Driving Activity In The Gene Transplant Market?
Major companies operating in the gene transplant market are Bayer AG, Novartis AG, CSL Behring LLC, Charles River Laboratories International Inc., BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., Ultragenyx Pharmaceutical Inc., CRISPR Therapeutics AG, Beam Therapeutics Inc., Rocket Pharmaceuticals Inc., Voyager Therapeutics Inc., Sangamo Therapeutics Inc., Editas Medicine Inc., Krystal Biotech Inc., bluebird bio Inc., Orchard Therapeutics plc, 4D Molecular Therapeutics Inc., Solid Biosciences Inc., uniQure N.V., MeiraGTx Holdings plc
Access The Complete Gene Transplant Market Report:
https://www.thebusinessresearchcompany.com/report/gene-transplant-global-market-report
Which Region Commands The Largest Share Of The Gene Transplant Market?
North America was the largest region in the gene transplant market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene transplant market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Gene Transplant Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=28232&type=smp
Browse Through More Reports Similar to the Global Gene Transplant Market 2026, By The Business Research Company
Genes Therapy Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report
Recombinant Dna Technology Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/recombinant-dna-technology-global-market-report
Gene Editing Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
